Empress Medical

Company Overview

Snapshot

Founded in April 2019, Empress Medical operates with 1–10 employees. The company has secured funding across one round from Med Venture Holdings to develop fibroid treatment solutions.

Business overview

Empress Medical is a Health Tech & Life Sciences company focused on developing innovative fibroid treatment solutions. The company's core technology involves an easy-to-use laparoscopic system designed to treat symptomatic uterine fibroids by inducing fibroid tissue ischemia, thereby reducing the need for hysterectomies and preserving fertility. Empress Medical aims to change the standard of care for women worldwide, making uterus-preserving fibroid treatment accessible to a broader base of underserved women. The company operates within the Medical Devices, Medical Treatment & Therapeutics sectors, targeting both healthcare providers and women consumers.

Company Intelligence Q&A

What is Empress Medical's primary focus?

Empress Medical is focused on developing fibroid treatment solutions to change the standard of care for women globally, aiming to reduce hysterectomies and preserve fertility through accessible laparoscopic technology.

When was Empress Medical founded?

Empress Medical was founded in April 2019.

What is the core technology developed by Empress Medical?

Empress Medical's core technology is the Empress system, a laparoscopic technology designed to treat symptomatic uterine fibroids by inducing fibroid tissue ischemia through sutures wrapped around the fibroid, leading to necrosis of the fibroid tissue.

What markets does Empress Medical target?

Empress Medical targets the healthcare market, specifically providers, and aims to serve women globally by offering uterus-preserving fibroid treatment options.